Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Miriam Tendler

2PUBLICATIONS

7CO-AUTHORS

NanomedicineFish pests and diseases

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Apr 23, 2025

The Sm14+GLA-SE Recombinant Vaccine Against <i>Schistosoma mansoni</i> and <i>S. haematobium</i> in Adults and School Children: Phase II Clinical Trials in West Africa.

Amadou Tidjani Ly, Doudou Diop, Modou Diop

|Oct 27, 2022

Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase Ib Clinical Trial Targeting Healthy Young Women.

Marília Santini-Oliveira, Patrícia Machado Pinto, Tatiane Dos Santos

Pageof 1

Frequent Collaborators

2 joint publications

Marília Sirianni Dos Santos Almeida

1 joint publications

Marília Santini-Oliveira

1 joint publications

Amadou Tidjani Ly

1 joint publications

Rhea N Coler

1 joint publications

Celso R Ramos

1 joint publications

Jacques-Noël Tendeng

1 joint publications

Daniella Arêas Mendes-da-Cruz

Frequent Collaborators

2 joint publications

Marília Sirianni Dos Santos Almeida

1 joint publications

Marília Santini-Oliveira

1 joint publications

Amadou Tidjani Ly

1 joint publications

Rhea N Coler

Top Related Videos

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from <em>Chlamydia muridarum</em> for Vaccine Development

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from <em>Chlamydia muridarum</em> for Vaccine Development

Published on : Mar 16, 2022

A High-throughput <em>Shigella</em>-specific Bactericidal Assay

A High-throughput <em>Shigella</em>-specific Bactericidal Assay

Published on : Feb 27, 2019

See more related videos

Top Related Videos

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from <em>Chlamydia muridarum</em> for Vaccine Development

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from <em>Chlamydia muridarum</em> for Vaccine Development

Published on : Mar 16, 2022

A High-throughput <em>Shigella</em>-specific Bactericidal Assay

A High-throughput <em>Shigella</em>-specific Bactericidal Assay

Published on : Feb 27, 2019

See more related videos